SEQENS is a global partner in health, personal care and specialty ingredients. They empower innovation to bring the best solutions to our customers, with a constant concern for sustainability. Relying on the skills of 3300 employees, they leverage a worldwide manufacturing network, and state-of-the-art R&D centers.
As an end-to-end player across the value chain, SEQENS offers a broad range of active ingredients, pharmaceutical intermediates, personal care & specialty ingredients. They innovate, develop and industrialize the most demanding molecules, and implement the best available technologies.

As a leading player of the health industry, SEQENS is committed to the therapies of the future and personalized medicine.

Driven by a culture of excellence and a strong entrepreneurial spirit, they share values such as unity, agility, and reactivity. They provide the highest level of service and quality to more than 1500 customers around the world while acting ethically in accordance to our strong CSR program.

Streamline your development process with Seqens’ one-stop-shop CDMO services. They offer integrated support for all stages of your program, from discovery and preclinical studies to clinical development, market authorization, and even ongoing commercial manufacturing. This ensures seamless handoffs and reduces overall development timelines.

– Therapeutic areas: Oncology

– Based in: Ecully (FRANCE) & Devens (Boston, US)

– Employees: 500+

– Created in: 2003